Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Return on Equity (2016 - 2026)

Biomerica's Return on Equity history spans 16 years, with the latest figure at 1.08% for Q1 2026.

  • Quarterly results put Return on Equity at 1.08% for Q1 2026, down 18.0% from a year ago — trailing twelve months through Feb 2026 was 1.08% (down 18.0% YoY), and the annual figure for FY2025 was 0.93%, down 29.0%.
  • Return on Equity for Q1 2026 was 1.08% at Biomerica, down from 0.84% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.48% in Q1 2022 to a low of 1.08% in Q1 2026.
  • The 5-year median for Return on Equity is 0.81% (2023), against an average of 0.8%.
  • The sharpest move saw Return on Equity plummeted -59bps in 2023, then skyrocketed 34bps in 2024.
  • Year by year, Return on Equity stood at 0.71% in 2022, then increased by 16bps to 0.6% in 2023, then crashed by -75bps to 1.06% in 2024, then rose by 20bps to 0.84% in 2025, then dropped by -28bps to 1.08% in 2026.
  • According to Business Quant data, Return on Equity over the past three periods came in at 1.08%, 0.84%, and 0.79% for Q1 2026, Q4 2025, and Q3 2025 respectively.